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Diverse Genotypes of Kaposi’s Sarcoma Associated
Herpesvirus (KSHV) Identified in Infant Blood
Infections in African Childhood-KS and
HIV/AIDS Endemic Region
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1Virology Department, University Teaching Hospital, University of Zambia Medical School, Lusaka, Zambia
2Pathogen Molecular Biology Unit, Department of Infectious Diseases, London School of Hygiene & Tropical Medicine,
Keppel St., University of London, London WC1E 7HT, United Kingdom
Kaposi’s sarcoma-associated herpesvirus (KSHV
or HHV-8) has been associated with several
neoplasias, including childhood endemicKaposi’s
sarcoma (KS). It is possible that strain genotypes
could contribute to the differences in regional
presentation (mainly sub-Saharan Africa), child-
hood infection, lack of male sex bias, distinct
disseminated forms and rapid fatality observed
for childhood endemic KS. Early studies, at the
advent of the HIV/AIDS epidemic, identified
only the K1-A5 genotype in childhood KS biop-
sies as well as blood of a few HIV positive
and negative febrile infants in Zambia, a highly
endemic region. This current enlarged study
analyses blood infections of 200 hospitalized
infants (6–34 months age) with symptoms of
fever as well as upper respiratory tract infection,
diarrhoea, rash or rhinitis. KSHV and HIV virae-
mia and were prevalent in this group, 22% and
39%, respectively. Multiple markers at both
variable ends of the genome (K1, K12, and
K14.1/K15) were examined, showing diverse
previously adult-linked genotypes (K1 A2, A5, B,
C3, D, with K12 B1 and B2 plus K14.1/K15 P or M)
detected in both HIV positive and negative
infants, demonstrating little restriction on KSHV
genotypes for infant/childhood transmission in
a childhood endemic KS endemic region. This
supports the interpretation that the acquisi-
tion of childhood KSHV infections and subse-
quent development of KS are due to additional
co-factors. J. Med. Virol. 79:1555–1561,
2007.  2007 Wiley-Liss, Inc.
KEY WORDS: Kaposi’s sarcoma associated
herpesvirus; HHV-8; childhood
endemic KS; HIV/AIDS; virus
genotype
INTRODUCTION
World-wide seroepidemiological analyses of Kaposi’s
sarcoma associated herpesvirus (KSHV) have associ-
ated this virus with KS. Analyses of tissue biopsies
by polymerase chain reaction (PCR) have identified
KSHV in KS: including HIV/AIDS associated, classic
(Mediterranean) and endemic (African). However, little
is known about childhood endemic KS, childhood
endemic KS (Sub-Saharan African regions). Childhood
endemic KS can be rapid and aggressive, often present-
ing as lymphadenopathy, having disseminated forms.
Childhood endemic KS has expanded since the HIV/
AIDS epidemic and extends to half of childhood cancers
in some African countries, while practically absent
in Europe or USA [Sarmati, 2004]. Is this a differ-
ent strain or one now spread by HIV/AIDS as an
emergent childhood disease? What are the implications
for vaccine development for control? Here this is
examined via analyses of genotypes in blood-borne
infant infections in Zambia, a childhood endemic KS
endemic region.
The highest childhood KSHV seroprevalence are
in several African countries including Nigeria (20%),
Uganda (21%), Zambia (47%), Egypt (44%), Tanzania
(58%), and Cameroon (32%); increasing with age, for
example, in adults the seroprevalence is higher in
Tanzania (89%) and Cameroon (62%), as reviewed
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[Sarmati, 2004; Mbulaiteye et al., 2006a]. In contrast,
childhood infection is rarely detected in USA and
Europe (3%) [Martro et al., 2004]. Childhood infection
in Africa can give rise to childhood endemic KS, but its
not know whether these strains are different from adult
infections, since frequent childhood infections are only
observed where there is evidence for mother to child or
close siblings transmission [Sarmati, 2004; Mbulaiteye
et al., 2006a]. KSHV seroprevalence in African children
isdifferent fromtherelatedgammaherpesvirus,Epstein–
Barr virus (EBV). By age three, 100% of children are
EBV seropositive in Nigeria, and 79% of their blood
DNA positive in Uganda, compared to KSHV where
in these populations 20% were seropositive and 10%
DNA positive in the respective studies [Martro et al.,
2004; Mbulaiteye et al., 2006b]. Thus, KSHV childhood
transmission is more restricted than EBV. Further, it
increases with age, different from EBV. Thus, could
distinct KSHV genotypes infect children compared to
adults, as for Herpes simplex virus (HSV), where HSV-1
primarily infects children via saliva, while HSV-2
sexually transmitted in adults?
Previous analyses of KSHV genetic diversity by PCR
on DNA extracted from adult KS biopsies followed by
nucleotide sequencing, show hypervariable genes at
either ends of the genome. These include K1 at the left
hand end (genotypes A–F) and, K12 and K14.1/K15
(genotypes B, P, M, N, O) at the right [Cook et al., 1999;
Poole et al., 1999; Zong et al., 1999; Kakoola et al., 2001].
In adult African endemic KS, two main K1 genotypes
were identified A5 and B, with only a minority of the
Eurasian C genotypes. While at the right hand end of
the genome, there are B genotypes in K12; while there
are P or M alleles for K14.1/K15, with P forms pre-
dominating in Eastern and Central Africa [Poole et al.,
1999; Lacoste et al., 2000; Kakoola et al., 2001]. In
contrast, in childhood endemic KS the K1-A5 genotype
had been identified suggesting specific strains may
infect the children (Zambia, 15 cases) [Kasolo et al.,
1998].
These diversity studies were on adult KS biopsies
which have relatively high copy numbers, thus ame-
nable to analyses. Less is known about virus genotypes
infecting general populations. In adults, studies on
PBMC DNA have detected K1-B and A5 genotypes in
Gambia and Uganda, with similar results for adults
from isolated Botswana tribes, where further variation
was demonstrated [Cook et al., 1999; Meng et al.,
1999; Whitby et al., 2004]. In infants, however, studies
of blood DNA from early infections have only been
characterized in Zambia, where previous related studies
identified K1-A5 after screening conserved genes (five
cases), similar to the childhood endemic KS genotype
identified in this population [Kasolo et al., 1998]. In
order to test whether there are restricted genotypes
in infant infections in childhood endemic KS endemic
regions, a further study was undertaken analyzing
blood DNA from a larger group of 200 infant patients,
using multiple markers for sites of variation from both
ends of the genome. Both HIV positive and negative
hospitalized infants were studied in this childhood KS
endemic region.
MATERIALS AND METHODS
Patients
Peripheral blood samples were sequentially collected
from 200 children, 6 months to 3 years, with non-specific
febrile illness during 2003, admitted to Paediatrics
Outpatients, University Teaching Hospital, Lusaka,
Zambia. Fever (>388C) was an inclusion criteria, a con-
sistent symptom from the few studies on primary KSHV
childhood infection [Kasolo et al., 1998; Andreoni et al.,
2002]; childhood endemic KS had not been diagnosed in
this cohort. Fever arising from malaria and bacterial
pneumonia were excluded and no other diagnosable
cause was reported. Samples were from spent blood
after routine diagnostic tests were performed. Protocols
were reviewed and approved by ethical committees at
the University Teaching Hospital, Zambia and London
School of Hygiene & Tropical Medicine, UK.
PCR
DNA was extracted from 200 ml whole blood (Qiagen,
Crawley, UK) and resuspended in 50 ml nuclease-free
H2O (Sigma, Gillingham, UK). PCR was carried in 20 ml
reactions using 1 ml DNA with PCR master mix
(Promega, Southampton, UK) and pfu polymerase
with plus primers for human prolactin gene, KSHV
K12 (646 bp, LGH2076/2075 and 407 bp, nested T07IF/
IR), K14.1/K15 (P,362 bp, and M,450 bpLGH2079,
LGH2033, and LGH2506), HIV (BUP/UP/nested BU3)
or HCMV (gN, gB1, and gB2, 150 bp) as described
[Kasolo et al., 1998; Nanteza et al., 1998; Poole et al.,
1999; Mattick et al., 2004; Whitby et al., 2004; Mattes
et al., 2005]; plus K1vri designed to detect all genotypes:
K1vri1 50TGTCTGCAGTCTGGCGGTTTG 30; K1vri2
50ACACAAGGTTTGTAAGACAGG30 and the conserved
K4 gene as control: K41 50 TGTGGATCCAACATGGG-
TATCGTT 30; K42 50 TTTGGATCCGAGTTGAGCTGT-
TTAC 30. A strict three lab policy for PCR (DNA-free lab
reagent addition, DNA lab for DNA addition, PCR lab
for amplifications) was used against contamination and
none detected; water negative controls for every 5–
10 reactions, were negative. KSHV sequences collected
had unique signatures.
Nucleotide Sequencing and Analyses
The amplified PCR products were purified (Qiagen
MinElute), followed by nucleotide sequencing using
BigDye v3.1 (ABI) and ABI 3730 analyzer as described
[Mattick et al., 2004]. Sequence analyses used Chromas
with Genbank comparisons using Blast and multiple
alignments with ClustalW [Chenna et al., 2003]. Phylo-
genetic trees were constructed using Phylip programs,
with Blosum62 distance matrix, a topological tree
algorithm and 100 bootstrap analyses [Brodsky et al.,
1992; Felsenstein, 2004]. Sequence submitted to EBI/
Genbank.
J. Med. Virol. DOI 10.1002/jmv
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RESULTS
Detection of KSHV
DNA was extracted from peripheral whole blood
samples from the cohort of 200 febrile infants, hospi-
talized in Lusaka, Zambia. These were then analyzed
by PCR and sequencing using primers specific for KSHV
as well as human DNA control (Prolactin). All KSHV
sequences collected had unique signatures and there
was no evidence for PCR contamination. Moreover,
many sequences subsequently derived had not been
previously identified in the laboratory. One hundred
and forty-one samples were included in the analyses
which showed consistent results, and a positive human
prolactin gene control.
PCR detection of HIV and KSHV was also compared
with human cytomegalovirus (HCMV), another herpes-
virus related to morbidity and mortality in these HIV
positive children. The results showed HIV, KSHV, and
HCMV detected in 39%, 22%, and 11% infants, respec-
tively (Table I). KSHV and HCMV coinfections were
rare (3/14 HCMV positive). Although co-infections with
HIV were more frequently identified with KSHV than
with HCMV (65% vs. 47%) supporting the expansion of
this infection with HIV/AIDS consistent with studies in
adults.
Clinical Features KSHV Infected Infants
The PCR reaction (1/50 of 0.2 ml blood with sensitivity
of 10–100 copies) detected at least 2,500 copies/ml blood,
consistent with KSHV viremia. Given the ages of the
patients (6–34 months), these are most likely primary
infections, with possible maternal or sibling trans-
mission through non-sexual routes as suggested pre-
viously for this population and neighboring regions
[He et al., 1998; Mbulaiteye et al., 2003, 2006a; Dedicoat
et al., 2004]. Fever was the inclusion criteria and other
J. Med. Virol. DOI 10.1002/jmv
TABLE I. KSHV Genotypes in Hospitalized Febrile Infants (6–34 months) in Zambia
Patienta HIV HCMV KSHV K1 K12 K14.1/15 Age Symptoms
K2 þ  þ A5 B1 P 6 mo URTI
K3   þ A5 B1 P 8 mo URTI
K4 þ  þ A5 B2 P 19 mo URTI, Rash
K33  þ  — — — 6 mo URTI
K35 þ  þ un B1 P 11 mo URTI, Diarrhoea
K37 þ  þ un B2 P 15 mo Fever
K42   þ un B2 P 11 mo Fever
K46 þ  þ B B1 un 7 mo Fever, Rhinitis
K50 þ  þ A2 B2 P 10 mo URTI
K54 þ þ þ A2 B1 P 24 mo Fever
K55 þ  þ un B1 P 29 mo Fever
K57 þ þ  — — — 17 mo Fever, Diarrhoea
K58 þ  þ A2 B1 P 3 yr Fever
K60  þ  — — — 14 mo Fever
K61 þ þ  — — — 14 mo Fever, Rash
K73 þ  þ A2 B2 P 13 mo URTI
K74 þ  þ A5 B2 P 11 mo Fever
K75 þ  þ un B2 un 12 mo Fever
K78   þ un B1 P 15 mo URTI
K79 þ  þ B B1 P 19 mo Fever
K86 þ þ  — — — 6 mo Fever
K91 þ  þ un B1 P 10 mo URTI, Diarrhoea
K93 þ þ þ un B2 un 22 mo Fever, Diarrhoea
K111   þ ABCD B1 un 9 mo Fever
K113   þ B un un 11 mo Fever
K117 þ  þ B B1 P 16 mo URTI
K118 þ  þ C3 un M 27 mo Fever, Diarrhoea
K135 þ þ  — — — 20 mo Fever
K136 þ  þ A5 B2 P 23 mo URTI
K137  þ þ A3 un un 6 mo Fever
K140   þ C3 un un 8 mo Fever
K141  þ  — — — 19 mo URTI, Diarrhoea
K149 þ  þ C3 un un 30 mo Fever, Diarrhoea
K162   þ C3 un un 11 mo Fever
K163   þ un B1 un 34 mo Fever
K164   þ C3 un un 14 mo URTI
K166  þ  — — — 17 mo URTI
K180  þ  — — — 9 mo Fever
K186   þ C3 un un 11 mo Fever
K190  þ  — — — 21 mo URTI and Rash
K192 þ þ  — — — 18 mo Fever and Rash
K199   þ C3 un un 9 mo Fever
un, KSHV DNAþ, but undetectable by primers indicated; mo, months age; yr, year.
aPatients positive for KSHV or HCMV are shown URTI, upper respiratory tract infection [Fever with Rhinitis or Pharyngitis or tonsillitis].
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hospital diagnosed causes of fever were excluded
(malaria or bacterial infections). Amongst the 31 infants
who were PCR positive for KSHV, upper respiratory
tract infections were the most common symptom 45%
(14/31), followed by diarrhea 19% (6/31), rash 3% (1/31)
and rhinitis 3% (1/31) (Table I).
Nucleotide Sequencing and Genotype Analyses
Many samples were at the limit of detection by PCR,
which restricted subsequent multiple analyses by
nucleotide sequencing. The PCR positive K1 loci was
first examined by sequencing. The results showed
the K1 A5 genotype, previously identified in infected
children and in childhood KS in this region, but also
unexpected diversity. The K1 A5 genotype was common
23% (5/22), now linked here with K12 B1 or B2 and
K14.1 P genotypes, consistent with previous results for a
distinct strain in this region (Table I and Fig. 1), and
presenting with respiratory symptoms (4/5). However,
also shown were K1-B (4/22), (prevalent in African adult
KS) as well as K1-A2, A3, and C3, previously common
in adult Mediterranean/Asian/Europe KS (C3, 7/22).
There were HIV positive and negative examples of all.
The Zambian infant blood KSHV sequences clustered
with representative of K1 A, B, C, or D genotypes from
adult KS biopsy samples (Fig. 2).
At the loci from the right hand of the genome K12 and
K14.1/K15 genotypes were identified, using primers to
amplify regions as characterized previously [Poole et al.,
1999]. Previous studies showed divergence of nucleotide
sequences of K12 at selected positions, mostly intergenic
non-coding, and some used as representative genotypes
(Fig. 3). There were 21 Zambian infant K12 genotypes
identified and these clustered with K12 B1 and B2
genotypes, similar to sequences identified in adult KS
biopsies in other parts of Africa as shown [Poole et al.,
1999; Kakoola et al., 2001] (Fig. 3). The PCR based
assay for the K14.1/15 distinguishes by size the P or M
genotypes. The dominance of the K14.1/15 P genotype
(17/18) is in agreement with previous studies showing
predominance in Eastern African regions also in adult
KS biopisies (Table I) [Lacoste et al., 2000]. For all sites
analyzed some samples could not be detected by the
primers used, suggesting further diversity.
One K1 sequence overlapped all of the genotypes,
ABCD (K111), either a local progenitor virus or effects
of recombination (Figs. 1 and 2). This was distinct from
previous progenitor strains (K1-43Berr closest, 18%
divergence) [Lacoste et al., 2000; Whitby et al., 2004].
However, the K12 B1 genotype from this sample was
similar to other B1 sequences from the region.
DISCUSSION
In earlier studies, of a childhood endemic KS region,
Zambia, analyses of blood infection in five infants
showed only K1-A5 genotypes and this correlated with
the genotype identified in different infant and childhood
KS samples [Kasolo et al., 1998]. Here the origin of the
J. Med. Virol. DOI 10.1002/jmv
13      * <.................VRi loop...........>*  85 Reference Type
FRGLLSLS LLSSPNLCPG VISTPYKLTC LSNASLPISW YCNNTRLFRP TETTLFPVTI ACNFTCVEQS GHRQS BCBLR A1
-------- ---------- ------T--- ---------- -------L-L –-RRVILD-- ---------- ----- BC1   A2
-------Y V--------- ------T--- --DS------ ---D---W-L –KP--TIDI- T--------- ----- BCBL1 A3
-------- ---------- ------T--- ---------- ---D-----L –R-------- P--------- ----- ZKS1  A4
-------Y –Q-------- ------T--- --D------- ---D---W-L -DQSFTVA-- T--------- ----- OKS3  A5
-------Y -Q-------- ------T--- P-AT---T-- ---D-----L -HD-FTV-NF I---S--G-- ---H-  BKS13 C1
-------Y -Q---P---- ------T--- P-DT---T-- ---D-----L -QD-ITV-SL V---S--G-- ---H-  SKS2  C2
-------- -Q-------- ------T--- P--T---T-- ---D---L-L -QQ-FTV-AL I---S--F-- ---H-  BC2   C3
-------Y -Q-------- -T----T-S- P-DP---T-- ---D-----I -QQ--TV-GV S------G-- ---H-  SKS1  C4
-------- ---------- ------T--- ---------- ---D-L-L-L -SP-VRA--- T--------- ----- SKS9  C5
-PK----H -P-F-H---- ------T--- P--R------ ---G---H-I -ASN-TVSSL T-----MTT- -PTH- RKS4  B
-P-----H -PAF-P---- -L--N-T--- P-D------- ---G-L-M-Y HR---TLMNL -A-W---N-- -ISH- ZKS3  D1
Patient
-------Y -Q-------- ------T--- ---------- ---D---W-L -NQSFTVA-- T--------- -----   K136 A5 
-------Y -Q-------- ------T--- --D------- ---D---W-L -NQSFTVA-- T--------- -----   K2   A5 
-------Y -Q-------- ------T--- --D------- ---D---W-L -NQSFTVA-- T--------- -----   K3   A5 
-------Y -Q-------- ------T--- --D------- ---D---W-L -DQS-TVA-V T------- K74  A5
-------Y -Q-------- ------T--- ---------- ---D---L-L -DRPFTVA-T T--------- -----   K4  A5
-------- ---------- ------T--- ---------- -------L-L --RRVILD-- ---------- -----   K73 A2
-------- ---------- ------T--- ---------- -------L-L --RRVILD-- ---------- -----   K50  A2
-------- ---------- ------T--- ---------- -------L-L --RRVILD-- ---------- ----    K58 A2
-------- ---------- ------T--- ---------- -------L-L --RRVILD-- ---------          K54  A2
-------Y VL-D------ ------T--- --DS------ ---D---W-L -KP--TIDI- T--------- --Q     K137 A3
-------- -Q-------R -S----T--- P--T---T-- ---D---L-L -QP--TVSNL I---S--G-F ---H- K149 C3
-------Y -QW------R -S----T--- P--T---T-- ---D---L-L -QP--TVSNL I---S--GTI         K186 C3
-------- -Q-------R -S----T--- P--T---T-- ---D---L-L -QP--TVSNL I---S--G-F ---H    K118 C3
-------- VQ-------R -S----T--- P--T---T-- ---D---L-L -QP-FTVSN- I---S--G-F ---     K199 C3
-------- -Q-------R -S----T--- P--T---T-- ---D---L-L -QP--TVSNL I---S--G-F ---H-   K140 C3
-------- -Q-------R -S----T--- P--T---T-- ---D---L-L -QP--TVSNL I---S--G-F ---H-   K162 C3
-------- -Q-------R -S----T--- P--T---T-- ---D---L-L -QP--TVSNL I---S--G-F ---H-   K164 C3
-PK----H -P-F-H---- -F----T--- P--R------ ---G---L-I -AS--TVSSL T------TT- -       K117  B
-PK----H -P-F-H---- -F----T--- P--R------ ---G---L-I -AS--TVSSL T------TT- -FTT-   K113  B
-PK----H -P-F-H---- --FK--T--- P--R------ ---G---H-I -ASN-TVSSL TG----MTT- -PTY-   K46   B
-P-----H -Q---HF--- ----S-T--- P-D------- ---G---L-L SQR--TVFKL S------GK- -PSH-   K111  ABCD
Fig. 1. Sequence analyses of K1 variable region, VRI loop, identifies genotype diversity in childhood
KSHV from African endemic region. The K1 region was PCR amplified from blood DNA, sequenced and
aligned against published representatives of K1 genotypes [Zong et al., 1999]. Dashes indicated identity.
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KSHV strains infecting infants is analyzed in a larger
study of blood infections in 200 hospitalized febrile
infants. KSHV sequences were identified in 31 individ-
uals. Given the young age (6–34 months) of the patients,
and the relative levels detected, these appeared to be
primary or early infections of which little is known. In
addition to fever, many had symptoms of upper respira-
tory tract infections or diarrhoea, but no evidence yet for
KS. Multiple loci were used to genotype the virus. The
results showed diverse adult-like genotypes identified in
both HIV positive or negative infants. These included
the following K1/K12/K14.1/15 genotypes: K1-A5, A2,
A3, B, C3 or A/B/C/D; K12-B1 or B2; K14.1/15 P or M.
It is also possible that given rapid increases in HIV/
AIDS in Zambia, the genotype pool of KSHV may have
expanded, leading to emergence of diverse childhood
infections. Recently, blood DNA from five older children
(>5 years age) in Uganda also showed 3 K1-A5 and 2
K1-B [Mbulaiteye et al., 2006a]. This is consistent with
results shown here, although here further loci have been
analyzed, with more diversity identified in the Zambian
region in a larger group of younger children and infants.
Thus, in a childhood KS endemic region, childhood
KSHV infection can occur with diverse genotypes.
J. Med. Virol. DOI 10.1002/jmv
Fig. 2. Phylogenetic tree of K1 sequences from childhood KSHV
blood infections in comparison to reference genotypes from Figure 1
shows extensive diversity. Scale and branch lengths indicate relative
genetic distance. In the bootstrap analyses the multiple alignment was
resampled generating 100 trees. Bootstrap values achieved are
expressed in percentages and placed at the nodes.
-
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Reference        
BCBLR A1   AC  A A C G T G C C T . . . T C A A A G T G T C C C A C C A T A T G T C
BC1 A2    A - - - - - - - - - . . . - - - - - A - - - - - - T - - - - - - C - -
ASM72 C     M - - - - - C – T C . . . - - G – G A C – C - - - - - - - C - - C - -
Ugd23 C    B1 - - - - C - - - . . . - - G G – A C - - - - - - - T – C - C C G –
Ugd15 B    B1 - - - A C - - - C C C - - G G – A C - - - - - - - T – C - C C G –
OKS3 A5   B1 - G - - C - - - . . . - - G G – A C - - - - - - - T – C – C C G T
Ugd12 A5   B2 - - A – C T - - . . . - - G - - A C - - T A T – T T – C – C C - -
Ugd19 B    B2 - - - - C - - - . . . - - G - - A C - - T A T – T T – C – C C - -
0KS4 B    B2  G - - - - C - - - . . . - - G - - A C - - T A - - T T – C – C C - -
Patient
K46 B    B1 - - - - - C - - - . . . - - G G – A C - - - - - - - T – C - C C G –
K2 A5   B1  G - - - C - - - . . . - - G G – A C - - - - - - - T – C - C C G –
K3 A5   B1 - G - - - C - - - . . . - - G G – A C - - - - - - - T – C - C C G –
K54 A2   B1 - - G - - C - - - . . . - - G G – A C - - - - - - - T – C - C C G –
K58 A2   B1 - - G - - C - - - . . . - - G G – A C - - - - - - - T – C - C C G –
K55 un   B1 - - G - - C - - - . . . - - G G – A C - - - - - - - T – C – C C G T 
K79 un   B1 - - G - - C - - - . . . - - G G – A C - - - - - - - T – C - C C G –
K91 un   B1 - - G - - C - - - . . . - - G G – A C - - - - - - - T – C - C C G –
K35 un   B1 G - - C - - - . . . - - G G – A C - - - - - - - T – C - C C G –
K111 ABCD B1 – A C - - - - - - - T – C – C C G -
K78 un   B1 – A C - - - - - - - T – C – C C 
K163 un   B1 – A C - - - - - - - T – C – C C 
K50 A2   B2  G - - - - C - - - . . . - - G - - A C - - T A T – T T – C – C C - -
K37 un   B2  G - - - - C - - - . . . - - G - - A C - - T A T – T T – C – C C - -
K4 A5   B2 - - - - C - - - . . . - - G - - A C - - T A T – T T – C – C C - -
K73 A2   B2 - - . . . - - G - - A C - - T A T – T T – C – C C 
K42 un   B2 - - . . . - - G - - A C - - T A T – T T – C – C C 
K75 un   B2 - - . . . - - G - - A C - - T A T – T T – C – C C 
K93 un   B2 - - . . . - - G - - A C - - T A T – T T – C – C C 
K136 A5   B2 - . . . - - G - - A C - - T A T – T T – C – C C 
K74 A5   B2 - - A C - - T A T – T T – C – C C 
K117 B    B2 – A C - - T A T - T T – C – C C 
Fig. 3. Nucleotide changes in the K12 region shows B genotypes identified in African regions. Reference
genotypes are shown (A, AC, M, B1, and B2), including Ugandan reference sequences from adult KS biopsy
materials, compared to the Zambian infant patients blood genotypes showing B1 and B2. The K12 segment
is in the reverse complement orientation (coding) from the genomic sequence. The positions of nucleotide
variation and reference sequences are as shown previously with position 1 as in [Poole et al., 1999; Kakoola
et al., 2001] or 118,065 in the BC1 genomic sequence, or position 51 in Poole et al. [1999], (positions 22 is
30, and 64 is 115 in Poole et al. [1999]). K12 ORF, Kaposin A, ends at position 147 as in Poole et al. [1999] and
Kakoola et al. [2001] or 117,919 in the BC1 genome [Russo et al., 1996]. The PCR product was from 118,
116–117, 469. Hyphens and dots indicate identical or deleted residues.
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Despite the diversity of genotypes identified in the
infant blood KSHV infections, is there any evidence for
distinct strains for childhood transmission? The K1A5
genotype is prevalent in KS biopsy samples from
patients in regions of Africa where there is childhood
endemic KS [Kasolo et al., 1998; Lacoste et al., 2000;
Kakoola et al., 2001]. Furthermore, the P genotype of
K14.1/15 is also linked to this region [Lacoste et al.,
2000], where only one M genotype was identified.
Moreover, only the K12 B genotype (both B1 and B2)
was identified in these infant infections, and these
genotypes are dominant in adult KS identified in other
African regions [Poole et al., 1999; Lacoste et al., 2000;
Kakoola et al., 2001]. Most of the K12 variation is in the
30 non-coding intergenic region. However, the encoded
Kaposin A is a tumorigenic transforming gene interact-
ing with cytohesin-1 integrin regulator, and two coding
changes were identified (Fig. 4) [Muralidhar et al., 1998;
Kliche et al., 2001]. One shown in some B1 genotypes,
C64G gives rise to Leu34 to Val, though conservative, it
disrupts an LXXLL motif (to LXXVL), reported required
for cellular transformation [Tomkowicz et al., 2005]. The
other substitution is divergent, G112C, giving Ala50 to
Pro in all B genotypes compared to both reference M and
P type genomes (BC1 and GK18, respectively) [Russo
et al., 1996; Rezaee et al., 2006]. Thus several genotype
markers may link with childhood endemic KS endemic
regions. However, the observation of multiple K1 geno-
types and past evidence for linked genome diversity
[Poole et al., 1999], suggests multiple KSHV strains can
be transmitted to infants.
Since the data shown here indicates there does not
appear to be any strain restriction for infant infection
in a region endemic for childhood KS, this implicates
other cofactors for childhood KSHV transmission and
KS development. Seroepidemiological studies on KSHV
transmission, identify factors including genetic predis-
position, low socioeconomic status, immunosuppresion
from HIV/AIDS or other influences, plus surface water
exposure, possibly linking to hygiene [DeSantis et al.,
2002; Mbulaiteye et al., 2003, 2005; Plancoulaine et al.,
2003; Klaskala et al., 2005]. In this regard, evidence for
mother to child or close siblings transmission in African
KS endemic populations has been demonstrated [He
et al., 1998; Mbulaiteye et al., 2003, 2006a; Dedicoat
et al., 2004] with virus detected in saliva and urine
[Beyari et al., 2004; Brayfield et al., 2004; Mbulaiteye
et al., 2004]. Factors for development of adult KS
require KSHV seropositivity, and include linkage to
higher socioeconomic status, water exposure, HIV/
AIDS immunosuppression, or immunogenetic regula-
tion [Ziegler et al., 1997, 2003; Sitas and Newton, 2001;
Gaya et al., 2004]. However, not all African countries
with high childhood KSHV seroprevalence have high
childhood endemic KS, thus additional factors affect
childhood endemic KS development. Whether these
African childhood infections with diverse KSHV geno-
types as shown here, have differences in subsequent
KSHV transmission or KS development, remains to be
determined and has important implications for vaccine
design.
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